<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03170518</url>
  </required_header>
  <id_info>
    <org_study_id>CR108298</org_study_id>
    <secondary_id>2016-005223-88</secondary_id>
    <secondary_id>28431754DIA3018</secondary_id>
    <nct_id>NCT03170518</nct_id>
  </id_info>
  <brief_title>A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (&gt;=10 to &lt;18 Years) With Type 2 Diabetes Mellitus</brief_title>
  <official_title>A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to &lt;18 Years) With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Janssen Research &amp; Development, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Janssen Research &amp; Development, LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of canagliflozin relative to placebo on
      glycated hemoglobin (HbA1c) after 26 weeks of treatment, and to assess the overall safety and
      tolerability of canagliflozin after 52 weeks of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 21, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 28, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Glycated Hemoglobin (HbA1c) From Baseline at Week 26</measure>
    <time_frame>Baseline (Day 1) and Week 26</time_frame>
    <description>Change from baseline in HbA1c at Week 26 will be analyzed using a mixed model for repeated measures (MMRM).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Fasting Plasma Glucose (FPG) From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26, and Week 52</time_frame>
    <description>Change from baseline in FPG at Week 26 and Week 52 will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HbA1c less than (&lt;)7.5 percent (%) at Week 26 and Week 52</measure>
    <time_frame>Week 26 and Week 52</time_frame>
    <description>The percentage of participants achieving HbAIc &lt;7.5% at Week 26 and Week 52 will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HbA1c &lt;7.0% at Week 26 and Week 52</measure>
    <time_frame>Week 26 and Week 52</time_frame>
    <description>The percentage of participants achieving HbAIc &lt;7% at Week 26 and Week 52 will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HbA1c &lt;6.5% at Week 26 and Week 52</measure>
    <time_frame>Week 26 and Week 52</time_frame>
    <description>The percentage of participants achieving HbAIc &lt;6.5% at Week 26 and Week 52 will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Rescue Therapy</measure>
    <time_frame>Baseline (Day 1) up to Week 26 and Week 52</time_frame>
    <description>Time from baseline to initiation of glycemic rescue therapy for participants not responding to treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who will Receive Rescue Therapy</measure>
    <time_frame>Week 26 and Week 52</time_frame>
    <description>Percentage of participants receiving rescue therapy will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Body Weight From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The change in body weight from Baseline to Week 26 and Week 52 will be assessed.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Body Mass Index (BMI) From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>Change from baseline in BMI at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percent Change in Fasting Plasma Lipid Levels From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The percentage change from baseline in fasting plasma lipids (low-density lipoprotein-cholesterol [LDL-C], high-density lipoprotein-cholesterol [HDL-C], total cholesterol, non-HDL-C, and triglycerides) at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percent Change in LDL-C to HDL-C Ratio and Non-HDL-C to LDL-C Ratio From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The percentage change from baseline in ratio of LDL-C to HDL-C and non-HDL-C to LDL-C at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Systolic Blood Pressure From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The change in systolic blood pressure from baseline to Week 26 and week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Diastolic Blood Pressure From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The change in systolic blood pressure from baseline to Week 26 and week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in HbA1c From Baseline at Week 12 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 12 and Week 52</time_frame>
    <description>Change from Baseline in HbA1c at Week 12 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Growth Velocity From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The change in growth velocity from baseline at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Tanner Staging From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>The change in tanner staging from baseline at Week 26 and Week 52 will be assessed. A low stage (Stage I) corresponds to a pre-pubertal stage and a high stage (Stage V) to an adult stage.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bone Turnover Marker: Serum Osteocalcin From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>Change from baseline in serum osteocalcin (bone turnover marker) at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bone Turnover Marker: Serum Collagen Type 1 Carboxy-Telopeptide (CTx) From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>Change from baseline in serum collagen Type 1 CTx (bone turnover marker) at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Urinary Albumin/Creatinine Ratio (ACR) From Baseline at Week 26 and Week 52</measure>
    <time_frame>Baseline (Day 1), Week 26 and Week 52</time_frame>
    <description>Change from baseline in urinary ACR at Week 26 and Week 52 will be assessed.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Single-blind run-in Period: Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 1 placebo tablet matching canagliflozin 100 milligram (mg) once-daily during the 2-week single-blind placebo run-in period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double-blind Treatment Phase: Canagliflozin or Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Canagliflozin 100 mg/matching placebo once-daily during first 12 weeks. At Week 13, participants who have glycated hemoglobin (HbA1c) of greater than or equal to (&gt;=)7.0 percent (%), estimated glomerular filtration rate (eGFR) &gt;=60 milliliter/minute/1.73 meter square (mL/min/1.73 m^2) will be re-randomized to either remain on canagliflozin 100 mg/matching placebo or up-titrate to canagliflozin 300 mg/matching placebo till Week 52.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canagliflozin 100 mg</intervention_name>
    <description>Canagliflozin 100 mg tablet will be administered orally (by mouth) once-daily.</description>
    <arm_group_label>Double-blind Treatment Phase: Canagliflozin or Placebo</arm_group_label>
    <other_name>JNJ-28431754</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canagliflozin 300 mg</intervention_name>
    <description>Canagliflozin 300 mg tablet will be administered orally once-daily.</description>
    <arm_group_label>Double-blind Treatment Phase: Canagliflozin or Placebo</arm_group_label>
    <other_name>JNJ-28431754</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo tablet will be administered orally once-daily.</description>
    <arm_group_label>Single-blind run-in Period: Placebo</arm_group_label>
    <arm_group_label>Double-blind Treatment Phase: Canagliflozin or Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants with a diagnosis of type 2 diabetes mellitus (T2DM)

          -  Random C-peptide at screening greater than (&gt;)0.6 nanogram/milliliter (ng/mL) (&gt;0.2
             nanomole/liter [nmol]/L])

          -  HbA1c of greater than or equal to (&gt;=)6.5 percent (%) to less than or equal to
             (&lt;=)10.5% and either

               1. On diet and exercise alone during the 8 weeks prior to screening

               2. On diet and exercise and a stable dose of metformin monotherapy &gt;=1,000 mg per
                  day for at least 8 weeks prior to screening

               3. On diet and exercise and a stable insulin monotherapy regimen for at least 8
                  weeks prior to screening

               4. On diet and exercise and a stable combination therapy with metformin and insulin
                  for at least 8 weeks prior to screening

        Exclusion Criteria:

          -  History of diabetic ketoacidosis (DKA), type 1 diabetes mellitus (T1DM), pancreas or
             cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy or
             maturity onset diabetes of the young (MODY)

          -  Participants on any antihyperglycemic agents (AHAs) other than metformin, or
             injectable insulin within 8 weeks of the first dose of study drug (Day 1)

          -  Repeated (2 or more over a 1-week period) fasting self-monitoring of blood glucose
             (SMBG) measurements &gt;270 milligram/deciliter (mg/dL) (&gt;15 millimole/liter [mmol/L])
             during the pretreatment phase, despite reinforcement of diet and exercise counseling

          -  Severe hypoglycemia within 6 months prior to Day 1

          -  History of hereditary glucose-galactose malabsorption or primary renal glucosuria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janssen Research &amp; Development, LLC Clinical Trial</last_name>
    <role>Study Director</role>
    <affiliation>Janssen Research &amp; Development, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Contact</last_name>
    <phone>844-434-4210</phone>
    <email>JNJ.CT@sylogent.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arkansas Childrens Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sutter Institute for Medical Research</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95821</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>American Institute of Research</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado School of Medicine/Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Research Center of Miami II Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nicklaus Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Columbus Clinical Services LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Asclepes Research</name>
      <address>
        <city>Spring Hill</city>
        <state>Florida</state>
        <zip>34609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Appalachian Clinical Research</name>
      <address>
        <city>Adairsville</city>
        <state>Georgia</state>
        <zip>30103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Endocrine Consultants Research</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904-4501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alas Science Clinical Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029-6500</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Carolinas Research Center, LLC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>WakeMed Clinical Research Institute</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington, LLC</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Buckeye Health and Research, LLC</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Research South, LLC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>AM Diabetes &amp; Endocrinology Center</name>
      <address>
        <city>Bartlett</city>
        <state>Tennessee</state>
        <zip>38133-4063</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sante Clinical Research</name>
      <address>
        <city>Kerrville</city>
        <state>Texas</state>
        <zip>78028</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sun Research Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MultiCare Health System</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto de Ciências Farmacêuticas de Estudos e Pesquisas - ICF</name>
      <address>
        <city>Aparecida De Goiânia</city>
        <zip>74935-530</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitário João de Barros Barreto - UFPA</name>
      <address>
        <city>Belem</city>
        <zip>66073-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Belo Horizonte</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Clínico do Lago</name>
      <address>
        <city>Brasilia</city>
        <zip>71625-009</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Diabetes Curitiba Ltda</name>
      <address>
        <city>Curitiba</city>
        <zip>80810-040</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Infantil Joana de Gusmão</name>
      <address>
        <city>Florianópolis</city>
        <zip>88025-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>UPCLIM - Unidade de Pesquisa Clínica de Marília</name>
      <address>
        <city>Marilia</city>
        <zip>17519-230</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centro de Pesquisas em Diabetes</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90035-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto da Criança com Diabetes do Rio Grande do Sul - ICDRS</name>
      <address>
        <city>Porto Alegre</city>
        <zip>91350-250</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Psiquiatria e Pesquisas Sandra Ruschel</name>
      <address>
        <city>Rio De Janeiro</city>
        <zip>22270-060</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital e Maternidade Dr Christovão da Gama</name>
      <address>
        <city>Santo André</city>
        <zip>09030-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>IPEC - Instituto de Pesquisa Clínica Ltda</name>
      <address>
        <city>São Paulo</city>
        <zip>01223-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto da Criança do HC-FMUSP</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericórdia de Votuporanga</name>
      <address>
        <city>Votuporanga</city>
        <zip>15500-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Capital Institute of Pediatrics</name>
      <address>
        <city>Beijing</city>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>201102</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>General Children's Hospital 'P. and A. Kyriakou'</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Athens Medical Center</name>
      <address>
        <city>Athens</city>
        <zip>15125</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Post Graduate Institute of Medical Education &amp; Research (PGIMER)</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>P.D. Hinduja National Hospital and - Medical Research Center</name>
      <address>
        <city>Mumbai</city>
        <zip>400016</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sir Ganga Ram Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jehangir Clinical Development Center Pvt Ltd</name>
      <address>
        <city>Pune</city>
        <zip>411001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Beer Sheba</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clalit Health Services Pediatric Diabetes clinic Armon Child Center</name>
      <address>
        <city>Haifa</city>
        <zip>3350121</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Bahiyah</name>
      <address>
        <city>Alor Setar</city>
        <zip>5460</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Pulau Pinang</name>
      <address>
        <city>George Town</city>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Permaisuri Bainun</name>
      <address>
        <city>Ipoh</city>
        <zip>30990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Tuanku Fauziah</name>
      <address>
        <city>Kangar</city>
        <zip>1000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital University Sains Malaysia</name>
      <address>
        <city>Kubang Kerian</city>
        <zip>16150</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Putrajaya</name>
      <address>
        <city>Putrajaya</city>
        <zip>62250</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Instituto Biomédico De Investigacion A.C.</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20127</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Pediatría</name>
      <address>
        <city>Coyoacan</city>
        <zip>4530</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios de Investigación Metabólicos y Cardiovasculares S.C.</name>
      <address>
        <city>Madero</city>
        <zip>89440</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St Lucas Clinical Research Center</name>
      <address>
        <city>Merida</city>
        <zip>97217</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Diagnostico Medicont</name>
      <address>
        <city>Miguel Hidalgo</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clinicos y Especialidades Medicas, S.C.</name>
      <address>
        <city>Monterrey</city>
        <zip>64620</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro De Investigacion Medica De Occidente, S.C.</name>
      <address>
        <city>Zapopan</city>
        <zip>45116</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Davao Doctors Hospital</name>
      <address>
        <city>Davao City</city>
        <zip>8000</zip>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Docbebet Diabetes Clinic</name>
      <address>
        <city>San Fernando City</city>
        <zip>2000</zip>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Dzieciecy im. J. Brudzinskiego w Bydgoszczy</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-667</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>SPSK nr 6 Slaskiego Uniwersytetu Medycznego w Katowicach, Gornoslaskie Centrum Zdrowia Dziecka</name>
      <address>
        <city>Katowice</city>
        <zip>40-752</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Specjalistyczny Szpital Dzieciecy</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-561</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gabinet Pediatryczny Artur Mazur</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-301</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szpital Pomnik Centrum Zdrowia Dziecka</name>
      <address>
        <city>Warszawa</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specjalistyczna Praktyka Lekarska Aspiro</name>
      <address>
        <city>Wrocław</city>
        <zip>50-341</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 1</name>
      <address>
        <city>Wrocław</city>
        <zip>50-368</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>China</country>
    <country>Greece</country>
    <country>India</country>
    <country>Israel</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Spain</country>
    <country>United Kingdom</country>
  </removed_countries>
  <link>
    <url>http://pam.sylogent.com/cr/CR108298</url>
    <description>To learn how to participate in this trial please click here.</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2017</study_first_submitted>
  <study_first_submitted_qc>May 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Canagliflozin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

